Caxton Associates (New York)’s Globus Medical GMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-18,501
| Closed | -$1.1M | – | 487 |
|
|
2023
Q2 | $1.1M | Sell |
18,501
-23,089
| -56% | -$1.37M | 0.16% | 133 |
|
|
2023
Q1 | $2.36M | Buy |
+41,590
| New | +$2.36M | 0.36% | 33 |
|
|
2022
Q3 | – | Sell |
-13,467
| Closed | -$756K | – | 537 |
|
|
2022
Q2 | $756K | Buy |
13,467
+6,079
| +82% | +$341K | 0.07% | 172 |
|
|
2022
Q1 | $545K | Buy |
+7,388
| New | +$545K | 0.04% | 205 |
|
|
2021
Q3 | – | Sell |
-3,866
| Closed | -$300K | – | 474 |
|
|
2021
Q2 | $300K | Buy |
+3,866
| New | +$300K | 0.03% | 284 |
|
|
2020
Q4 | – | Sell |
-4,732
| Closed | -$234K | – | 190 |
|
|
2020
Q3 | $234K | Buy |
+4,732
| New | +$234K | 0.02% | 226 |
|
|
2019
Q1 | – | Sell |
-9,381
| Closed | -$406K | – | 420 |
|
|
2018
Q4 | $406K | Buy |
9,381
+395
| +4% | +$17.1K | 0.06% | 126 |
|
|
2018
Q3 | $510K | Buy |
+8,986
| New | +$510K | 0.04% | 184 |
|
|
2017
Q4 | – | Sell |
-15,400
| Closed | -$458K | – | 351 |
|
|
2017
Q3 | $458K | Buy |
+15,400
| New | +$458K | 0.02% | 318 |
|